Concepedia

Erik B. Nielsen

EB

32

Publications

2K

Citations

26

H-Index

1973

Active since

Affiliations

Novo Nordisk (Denmark)(Current)

Sankt Hans Hospital

Novo Holdings (Denmark)

University of Copenhagen

University of South Carolina

Erik B. Nielsen is an author at Novo Nordisk (Denmark) specializing in medicine, pharmacology, and neuropharmacology.

Top concepts

Publications per year

1973–2000

32

Publications

32

Characterization of tiagabine (NO-328), a new potent and selective GABA uptake inhibitor

Erik B. Nielsen, Peter D. Suzdak, Knud Erik Andersen et al. · European Journal of Pharmacology · 1991 · 232 citations

, , +9

<i>(R)‐N</i>‐[4,4‐Bis(3‐Methyl‐2‐Thienyl)but‐3‐en‐1‐yl]Nipecotic Acid Binds with High Affinity to the Brain γ‐Aminobutyric Acid Uptake Carrier

Erik B. Nielsen, Ursula Sonnewald, Lars J. S. Knutsen et al. · Journal of Neurochemistry · 1990 · 228 citations

NNC-711, a novel potent and selective γ-aminobutyric acid uptake inhibitor: pharmacological characterization

Peter D. Suzdak, Kristen Frederiksen, Knud Erik Andersen et al. · European Journal of Pharmacology · 1992 · 158 citations

, , +9

The synthesis of novel GABA uptake inhibitors. 1. Elucidation of the structure-activity studies leading to the choice of (R)-1-[4,4-bis(3-methyl-2-thienyl)-3-butenyl]-3-piperidinecarboxylic acid (Tiagabine) as an anticonvulsant drug candidate

Knud Erik Andersen, Frederik C. Groenwald, A. JOERGENSEN et al. · Journal of Medicinal Chemistry · 1993 · 151 citations

Comparison of the preclinical anticonvulsant profiles of tiagabine, lamotrigine, gabapentin and vigabatrin

Nils Ole Dalby, Erik B. Nielsen · Epilepsy Research · 1997 · 124 citations

, , +4

Rows per page

1–5 of 32